Delaware AG Can Pursue Fraud Claims Against Opioid Makers
Law360 (February 4, 2019, 9:59 PM EST) -- Delaware can move ahead with a case calling out drug manufacturers for downplaying the addictive nature of opioids, the state’s Superior Court ruled Monday, though it cut out claims against two major pharmacy chains as well as accusations of civil conspiracy.
The Superior Court refused motions to dismiss claims of consumer fraud and negligence against drugmakers Purdue Pharma LP and Endo Pharmaceuticals Inc., as well as those against distributors McKesson Corp., Cardinal Health Inc., AmerisourceBergen Corp., Anda Pharmaceuticals Inc. and H.D. Smith LLC.
The Delaware attorney general’s office filed the suit in January 2018, accusing the drug companies of lying to...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!